This story was originally published May 14.

Beckman Coulter Genomics has received CLIA certification for its sequencing services facility as it looks to develop assays for both Sanger and next-gen sequencing platforms.

The company announced the CLIA certification last week alongside the launch of a Sanger sequencing-based BRAF test — the first of other molecular diagnostic tests to come, according to Joseph Repp, vice president and general manager of Beckman Coulter Genomics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.